Its Phase 2/3 LIFT-AD Alzheimer's trial failed its primary endpoint, announced September 3, 2024 (global statistical test 0.08, P = .70)
VIBES works primarily in the stomach
It operates by interacting with growth hormone secretagogue receptors, triggering a cascade of biological events leading to elevated growth hormone levels
Toxicology and Applied Pharmacology 22:282.[Web of Science ] , [Google Scholar])
Most patients report noticeable appetite reduction within the first week, although it can take up to a month for the full effects to be experienced
Although recent reviews have described the role of GLP-1 RAs on cardiovascular risk in general, there is a lack of evidence synthesis on local actions of GLP-1 RAs in coronary arteries and the link of these mechanisms to coronary events (Garg et al., 2019